| FISV |
Report |
Adj. EPS (Q2 2026) |
BEAT |
pred ~$2.02 vs. cons $1.89 |
MEDIUM |
| FISV |
Report |
Adj. Revenue (Q2 2026) |
MISS |
pred ~$4.87B vs. cons $5.05B |
MEDIUM |
| FISV |
Report |
Financial Solutions Revenue (Q2 2026) |
MISS |
pred ~$2.32B vs. cons $2.39B |
MEDIUM |
| FISV |
Guide |
FY 2026 Adj. EPS (FY2026) |
UNCHANGED |
guide $8.00-$8.30 reaffirmed vs. cons ~$8.15 |
MEDIUM |
| FISV |
Guide |
FY 2026 Organic Revenue (FY2026) |
UNCHANGED |
guide 1-3% reaffirmed vs. cons ~2% |
MEDIUM |
| FISV |
Guide |
H2 2026 Revenue Acceleration (qualitative) |
UNCHANGED |
6-8% H2 growth reaffirmed with new CEO caveats |
LOW |
| FISV |
Return |
Day-1 residual (stock − beta × S&P 500) |
-4.0% |
— |
MEDIUM |
| FISV |
Return |
5-day cumulative residual |
-5.5% (FADE) |
FADE — sell-side trims revenue estimates post-print; EPS maintained but revenue quality concern lingers; short covering limits downside but does not reverse it |
MEDIUM |